| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 8.209 | 175.463 | 456.634 | 695.393 | 1.067.562 |
| Total Income - EUR | - | - | - | - | - | 8.209 | 215.280 | 457.341 | 719.121 | 1.072.234 |
| Total Expenses - EUR | - | - | - | - | - | 1.776 | 193.758 | 432.111 | 657.067 | 981.823 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 6.433 | 21.522 | 25.230 | 62.054 | 90.412 |
| Net Profit/Loss - EUR | - | - | - | - | - | 6.186 | 20.196 | 21.342 | 52.580 | 78.331 |
| Employees | - | - | - | - | - | 0 | 3 | 7 | 10 | 14 |
Check the financial reports for the company - Damy Ortomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 7 | 139.876 | 127.445 | 177.013 | 490.748 |
| Current Assets | - | - | - | - | - | 6.326 | 26.575 | 40.704 | 51.270 | 90.311 |
| Inventories | - | - | - | - | - | 0 | 14.284 | 15.770 | 20.449 | 12.784 |
| Receivables | - | - | - | - | - | 0 | 0 | 316 | 1.310 | 25.106 |
| Cash | - | - | - | - | - | 6.326 | 12.291 | 24.619 | 29.510 | 52.420 |
| Shareholders Funds | - | - | - | - | - | 6.228 | 26.285 | 47.709 | 54.279 | 131.033 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 105 | 140.166 | 120.440 | 174.004 | 450.026 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Damy Ortomed S.r.l.